Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MNPR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MNPR investment potential.

What is MNPR stock price today?

Get real-time MNPR stock price, historical data, and price charts on Financhill. Track MNPR performance with our advanced analysis tools.

Is MNPR a good investment?

Evaluate MNPR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MNPR stock?

To buy MNPR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MNPR?

View detailed market capitalization data and company valuation metrics for MNPR on our comprehensive analysis page.

What is the P/E ratio of MNPR?

Use our fundamental analysis tools to view MNPR P/E ratio and compare valuation metrics with industry peers.

What are MNPR earnings?

View MNPR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Monopar Therapeutics, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

MNPR
Monopar Therapeutics, Inc.

Last Price:

$74.46

Seasonality Move:

36.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

Monopar Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 222.6% based on the past 5 years of stock performance.
Monopar Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Is Monopar Therapeutics, Inc. Stock Undervalued?

The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 222.6% based on the past 5 years of stock performance.

Monopar Therapeutics, Inc. Stock Rating

Sell

Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. overpriced?

Monopar Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Monopar Therapeutics, Inc. Stock Price History

Is MNPR stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

monopartx.com

52-Week Data

52-Week High:

105.00

52-Week Low:

21.00

Prediction Charts

Market Cap:

498.6M

Price in USD:

74.61

Volume:

248.7K

Beta:

1.40

Technical Analysis

SMA50:

84.43

SMA100:

66.11

SMA200:

51.38

52-Wk Change:

207.65%

Stock Predictions

Is Monopar Therapeutics, Inc. stock public?

Yes, Monopar Therapeutics, Inc. is a publicly traded company.
What is the Monopar Therapeutics, Inc. stock quote today?

The Monopar Therapeutics, Inc. stock price is 74.61 USD today.
How to buy Monopar Therapeutics, Inc. stock online?

You can buy Monopar Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-24	92.94	92.75	100.50	90.00
Nov-25	93.06	88.47	98.00	85.91
Nov-26	88.03	87.36	88.88	83.86
Nov-28	87.66	86.18	91.79	84.00
Dec-1	84.88	83.06	87.97	82.27
Dec-2	83.48	75.94	84.04	75.69
Dec-3	77.48	77.19	79.65	74.00
Dec-4	75.47	79.47	79.90	75.47
Dec-5	79.79	80.38	85.01	79.50
Dec-8	80.40	76.43	83.87	75.27
Dec-9	76.82	75.44	78.95	74.51
Dec-10	75.13	78.22	79.31	74.85
Dec-11	78.72	77.05	79.02	75.00
Dec-12	76.51	74.61	76.90	73.63

Monopar Therapeutics, Inc. Earnings

Monopar Therapeutics, Inc. Earnings Report: Per Share Monopar Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics, Inc. Forecast Revenue Growth

Monopar Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.